IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(1.32) per share. This is a 100 percent decrease over losses of $(0.66) per share from the same period last year.
Raymond James Maintains Outperform on Univest Financial, Lowers Price Target to $31
Raymond James analyst William Wallace maintains Univest Financial (NASDAQ:UVSP) with a Outperform and lowers the price target from $34 to $31.